This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Origin Agritech Limited Reports Second Quarter Unaudited Financial Results For Three Months Ended March 31, 2011

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of crop seeds in China, today announced unaudited financial results for the second quarter ended March 31, 2011. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

FINANCIAL RESULTS OVERVIEW

During the second quarter of fiscal 2011, the Company generated revenues of RMB1.09 million (US$0.17 million), a decrease of 32.31% from RMB 1.60 million (US$0.24 million) generated in the three months ended March 31, 2010. The small amount of revenues this quarter is generated as a result of scrap sales. As a reminder, the majority of Origin’s revenues are recorded in the fiscal third quarter as a result of our revenue recognition policy. The goods already sold and shipped to customers can be seen as Deferred Revenue line on the balance sheet and the Advances from Customers records the advance cash receipts from customers this selling season.

Gross loss for the three months ended March 31, 2011 was RMB7.04 million (US$1.07 million) compared to RMB5.94 (US$0.87 million) in the same period of the prior year.

Total net operating expenses for the three months ended March 31, 2011 were RMB31.99 million (US$4.88 million) compared with RMB31.41 million (US$4.60 million) reported for the same period in 2010. Selling and marketing expenses were RMB7.71 million (US$1.18 million) for the second quarter of 2011, representing a decrease of 15.28% from RMB9.10 million (US$1.33 million) for the same period of the last year. General and administrative (“G&A”) expenses of RMB16.78 million (US$2.56 million) for the second quarter ended March 31, 2011, increased 13.17% from RMB14.83 million (US$2.17 million) for the three months ended March 31, 2010. Research and development (“R&D”) expenses increased by 30.8% to RMB9.80 million (US$1.49 million) for the three months ended March 31, 2011 from RMB7.49 million (US$1.10 million) for the same quarter last year. The increase in G&A expenses was in part due to the increase in non-cash charges this quarter, such as depreciation charges and fees related to stock option expense, as other major expenses within the G&A expenses category remained relatively flat. Meanwhile R&D expenses increased in line with our corporate goals of expansion of our biotechnology competencies in-house.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs